Sammy is an Australian researcher from Brisbane. He holds a BSc in Physics from The University of Queensland; as well as a dual MSc in Biofabrication from both the Queensland University of Technology and the University of Wurzburg. With prior experience in experimental optics and extensive work with melt-electrowriting, his interests have now turned towards volumetric bioprinting. As such, his project is focused on improving this technique to enable for the fabrication of both accurate and highly complex multicellular tissue engineering scaffolds within a matter of seconds.

Davide is an Italian biomedical engineer from Milan; he holds a MSc in Biomechanics and Biomaterials from Politecnico di Milano. He is strongly engaged by med-tech sector and spurred by challenges related to biofabrication combined to cell bioengineering. With previous experiences in 3D bioprinters, bio-inks design and 3D cell cultures, he started a PhD in Biofabrication and Regenerative Medicine. His project focuses on a new volumetric bioprinting process, capable of optogenetic stimulation to instruct cell fate, with the aim to build physiological-scale pancreas organoids that replicate human organ-level functionality.

Marième is a Senegalese biotechnology engineer, with a MSc in Synthetic Biotechnology from the École Supérieure de Biotechnologies de Strasbourg (France). She is enthusiastic about translational research and has experience with organ-on-chips platforms and cancer organoids. In 2021, she started her PhD in Biofabrication and Regenerative Medicine, within the VOLUME-BIO project. She is working on using a new volumetric bioprinting process to develop physiological-size bone marrow organoids that display near-physiological hematopoiesis.

Gabriel is an Austrian computer scientist; he holds an MSc in Biofabrication (Utrecht University). He started his PhD in 2022 under the supervision of Dr. Riccardo Levato. He has a background in software engineering and ample experience with different 3D printing systems. His PhD focuses on the convergence of printing technologies with a focus on machine learning as a tool to automate and enhance state of the art approaches in regenerative medicine.

Núria is originally from Barcelona where she obtained a BSc in Biotechnology specializing in Biomaterials and  developing ECM-like materials for electrospinning. Núria moved to Business Development in collaboration with the European Commission writing project proposals and building consortia for Horizon 2020, ERC and EiTHealth. During that stage, she obtained a post-graduate degree in IP protection and technology transfer. Núria holds an MSc in Biofabrication and started her PhD in 2022 in smart Organs on Chip. Her expertise ranges from developing printing technologies to tissue engineering and micro-perfused systems. 

Estée Grandidier is a French PhD student, with a MSc in biomedical engineering (École Polytechnique de Lausanne) and in biology (École Normale Supérieure de Lyon). She has research experience in the Lafont’s lab (Pasteur Institute), Schneeberger’s lab (Hospital of Innsbruck), Haase lab (EMBL Barcelona), Moser’s lab (EPFL) and Lewis lab (Harvard). Her project,  with Roel Deckers (UMCU) focuses on  vascularized cancer models for ultrasound-microbubble therapies. Over the course of her PhD, she aims to combine bioprinting, engineering, and biological mechanisms to design a comprehensive in vitro tumor tissue. 

Camille is a French PhD student holding a MSc in Chemistry and Chemical Engineering from the Institut National des Sciences Appliquées in Rouen (INSA Rouen Normandie). She has research experience in supramolecular chemistry in the Pilgrim's Lab (Nottingham) and in hydrogel and microgel synthesis and cell culture in the De Laporte's lab (DWI, Aachen). In 2024, she started her PhD at Utrecht University in Biofabrication and Regenerative Medicine. Her project focuses on the development of smart hydrogels for the volumetric bioprinting process to culture liver organoids.

Gaja is an Italian biomedical engineer with a Master's degree in Biomechanics and Biomaterials from Politecnico di Milano. She has hands-on experience with organs-on-chip, 3D cell culture, and innovative coating techniques, acquired at the Regenerative Medicine Technologies Lab in Bellinzona (Switzerland). Driven by her passion for in vitro modeling and space biotechnology, in 2024 she began her PhD in 3D Printing and Biofabrication for Regenerative Medicine, under the supervision of Riccardo Levato. Her research focuses on bioengineering the AGM niche to generate bona fide hematopoietic stem cells in vitro.

Charlotte is originally from Zimbabwe and holds a BSc in Medicine from the University of Groningen and an MSc in Biofabrication from Utrecht University. Currently a PhD student in the lab, Charlotte’s research focuses on engineering volumetrically bioprinted constructs, using organoids derived from multiple cell sources as building blocks, for advanced in vitro models of various tissues such as the liver and pancreas. Her work aims to develop a foetal liver-like niche for the expansion of haematopoietic stem cells, as well as creating perfusable pancreatic constructs for diabetes modelling and drug testing.

Originally from Barcelona, Nuria holds a MSc in biomedical sciences, with a specialization in stem cells and regenerative medicine from Leiden University. With previous research experience in the Geijsen lab (LUMC) and the Drost lab (Prinses Maxima Centre for paediatric oncology), she is, since 2025, a PhD candidate at Utrecht University under the supervision of Dr. Prof. Sabine Fuchs (UMCU) and Dr. Riccardo Levato. Over the course of her PhD, Nuria aims to combine stem cell research, gene editing and bioprinting technologies for the development of perfusable pancreatic constructs for diabetes modelling and drug testing.